Moving up:
Market News and Data brought to you by Benzinga APIs- Prothena Corp PRTA - up 24% - Reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.
- First Solar FSLR - up 20% - Sees FY2014 EPS $2.20-2.60; sees sales $3.70B-4.0B. Sees FY2015 EPS $4.50-6.00; sees sales $3.80B-4.30B.
- Inovio INO - up 10.5% - Reports Q4 EPS of $(0.07) vs $(0.03) est; revenue of $1.70M vs $1.36M est.
- Horizon Pharma HZNP - up 10% - announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.
- Vera Bradley VRA - up 7% - Reports Q4 EPS of $0.48 vs $0.46 est; revenue of $157.50M vs $146.86M est. Sees Q1 sales $116.0M-120.0M vs $123.10M est.
- KB Home KBH - up 6.8% - Reports Q1 EPS of $0.12 vs $0.08 Est; revenue of $450.70M vs $431.49M est.
- Synchronoss Technologies SNCR - up 5.9% - Wells Fargo released some bullish comments and feels confident in revenue outlook of cloud business.
- Central European Media Enterprises CETV - down 13% - Investors taking profits after the stock gained 6.9% on Tuesday.
- Kandi Technologies KNDI - down 10% - Raised $11 million in a private placement with two institutional investors for 606,000 shares valued at $18.24 per share. The company also issued 90,900 warrants struck at $22.80 per share which expires in 18 months.
- TheraputicsMD TXMD - down 9.6% - Announced the launch of an underwritten secondary public offering of 9,000,000 shares of its common stock.
- Orbitz OWW - down 9.2% - from Neutral to Sell and set the price target to $8.
- Castlight Health CSLT - down 8.2% - After gaining 155 percent on Friday, the first day of trading for the stock, investors continue to take profit.
- Manhattan Associates MANH - down 7.6% - Alimerka selected components from Manhattan's Supply Chain Commerce Solutions. The stock is giving back a fraction of its monster gains from the past 5 years.
- Geophysical Corporation IO - down 6% - Downgraded by Barclays from Overweight to Equalweight and lowered the price target from $5 to $4.
- Nu Skin NUS - down 5.6% - Temporarily suspending some promotional meetings in China.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
